mercredi 4 novembre 2015

Onco Actu du 4 novembre 2015

3.1 Tabac

Trial to study smoking-cessation therapy tailored to a smoker’s DNA [Washington University in St. Louis]

4. Dépistage, diagnostic et pronostic

Study: Only 1 in 5 US pancreatic cancer patients get this key blood test at diagnosis [Mayo Clinic]

Public don't realise screening can help prevent cancer [NRCI]

4.5 Dép., diag. & prono. - Colorectal

Naturally high oestrogen levels may lowen women's bowel cancer risk after menopause [NCRI]

4.9 Dép., diag. & prono. - Sein

Breast Cancer - Pipeline Review, 2015 [Report Buyer]

5. Traitements

Prostate cancer treatment time 'could be halved' with more intense radiotherapy [The Telegraph]

5.2 Pharma

Boehringer Ingelheim initiates pivotal programme for novel third-generation EGFR targeting lung cancer compound [Boehringer Ingelheim]

GSK aims to file up to 20 new drugs for approval by 2020 [Reuters]

5.2.1 Pharma - Partenariats

Sanofi inks a $1.5B deal to join BioNTech's growing list of oncology partners [FierceBiotech]

Bristol-Myers Squibb and the Johns Hopkins Kimmel Cancer Center Enter Into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Research Program [BMS]

GSK and Merck to Study Immunotherapy Combination as Potential Cancer Treatment [Merck]

6. Lutte contre les cancers

NCRI cancer conference day 2: big data, immunotherapy and prizes [Cancer Research UK]

6.11 Patients

Rerouted, not derailed: resuming a young life after cancer [Cancer World]